10-87053403-C-T

Variant summary

Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PM5PP3PP5_Moderate

The NM_005271.5(GLUD1):​c.1496G>A​(p.Gly499Asp) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 14/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G499S) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

GLUD1
NM_005271.5 missense, splice_region

Scores

11
6
1
Splicing: ADA: 0.9785
2

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 7.54

Publications

12 publications found
Variant links:
Genes affected
GLUD1 (HGNC:4335): (glutamate dehydrogenase 1) This gene encodes glutamate dehydrogenase, which is a mitochondrial matrix enzyme that catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate and ammonia. This enzyme has an important role in regulating amino acid-induced insulin secretion. It is allosterically activated by ADP and inhibited by GTP and ATP. Activating mutations in this gene are a common cause of congenital hyperinsulinism. Alternative splicing of this gene results in multiple transcript variants. The related glutamate dehydrogenase 2 gene on the human X-chromosome originated from this gene via retrotransposition and encodes a soluble form of glutamate dehydrogenase. Related pseudogenes have been identified on chromosomes 10, 18 and X. [provided by RefSeq, Jan 2016]
GLUD1 Gene-Disease associations (from GenCC):
  • hyperinsulinism-hyperammonemia syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 2 uncertain in NM_005271.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr10-87053404-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 16124.
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
PP5
Variant 10-87053403-C-T is Pathogenic according to our data. Variant chr10-87053403-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 16125.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005271.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLUD1
NM_005271.5
MANE Select
c.1496G>Ap.Gly499Asp
missense splice_region
Exon 12 of 13NP_005262.1P00367-1
GLUD1
NM_001318900.1
c.1097G>Ap.Gly366Asp
missense splice_region
Exon 12 of 13NP_001305829.1P00367-3
GLUD1
NM_001318901.1
c.995G>Ap.Gly332Asp
missense splice_region
Exon 15 of 16NP_001305830.1P00367-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLUD1
ENST00000277865.5
TSL:1 MANE Select
c.1496G>Ap.Gly499Asp
missense splice_region
Exon 12 of 13ENSP00000277865.4P00367-1
GLUD1
ENST00000915201.1
c.1544G>Ap.Gly515Asp
missense splice_region
Exon 12 of 13ENSP00000585260.1
GLUD1
ENST00000898383.1
c.1535G>Ap.Gly512Asp
missense splice_region
Exon 12 of 13ENSP00000568442.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
28
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Hyperinsulinism-hyperammonemia syndrome (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.53
D
BayesDel_noAF
Pathogenic
0.52
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.83
D
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.88
D
M_CAP
Pathogenic
0.31
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Pathogenic
3.6
H
PhyloP100
7.5
PrimateAI
Pathogenic
0.86
D
PROVEAN
Pathogenic
-6.1
D
REVEL
Pathogenic
0.87
Sift
Benign
0.052
T
Sift4G
Uncertain
0.054
T
Polyphen
0.28
B
Vest4
0.99
MutPred
0.90
Loss of glycosylation at S498 (P = 0.0455)
MVP
0.98
MPC
1.6
ClinPred
0.97
D
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.77
gMVP
0.97
Mutation Taster
=10/90
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.98
dbscSNV1_RF
Pathogenic
0.82
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121909734; hg19: chr10-88813160; API